PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0075/2023 : EMA decision of 10 March 2023 on the acceptance of a modification of an agreed paediatric investigation plan for eladocagene exuparvovec (Upstaza), (EMEA-002435-PIP01-18-M03)